Does RILPIVIRINE Cause Product dose omission issue? 702 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 702 reports of Product dose omission issue have been filed in association with RILPIVIRINE (EDURANT). This represents 10.0% of all adverse event reports for RILPIVIRINE.
702
Reports of Product dose omission issue with RILPIVIRINE
10.0%
of all RILPIVIRINE reports
0
Deaths
40
Hospitalizations
How Dangerous Is Product dose omission issue From RILPIVIRINE?
Of the 702 reports, 40 (5.7%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILPIVIRINE. However, 702 reports have been filed with the FAERS database.
What Other Side Effects Does RILPIVIRINE Cause?
Injection site pain (640)
Viral load increased (455)
Virologic failure (404)
Pathogen resistance (323)
Pain (297)
Off label use (274)
Product use in unapproved therapeutic environment (234)
Viral mutation identified (211)
Blood hiv rna increased (205)
Exposure during pregnancy (188)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which RILPIVIRINE Alternatives Have Lower Product dose omission issue Risk?
RILPIVIRINE vs RILUZOLE
RILPIVIRINE vs RIMABOTULINUMTOXINB
RILPIVIRINE vs RIMEGEPANT
RILPIVIRINE vs RIOCIGUAT
RILPIVIRINE vs RIPRETINIB